Search Results - "García Villanueva, Maria J"
-
1
O17 SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus, developed from RELESSER prospective database cohort
Published in Lupus science & medicine (14-03-2024)“…ObjectivePatients with Systemic lupus erythematosus (SLE) have a not uniform increased risk of serious infection. It is important to estimate the infection…”
Get full text
Journal Article -
2
New targets in systemic lupus (part 2/2)
Published in Reumatologia clinica (01-09-2012)“…Glucocorticoids, aspirin, conventional antimalarials and immunosuppressants are the mainstay of treatment of Systemic Lupus Erythematosus (SLE). Until…”
Get more information
Journal Article -
3
New therapeutic targets in systemic lupus
Published in Reumatologia clinica (01-07-2012)“…Glucocorticoids, aspirin, antimalarials and conventional immunosuppressants are the mainstay of treatment of Systemic Lupus Erythematosus (SLE). Until…”
Get more information
Journal Article -
4
Nuevas dianas terapéuticas en el lupus sistémico (parte 2/2)
Published in Reumatología clinica (01-09-2012)“…Resumen Glucocorticoides, aspirina, antipalúdicos e inmunosupresores convencionales constituyen la base del tratamiento del lupus eritematoso sistémico (LES)…”
Get full text
Journal Article -
5
Nuevas dianas terapéuticas en el lupus sistémico (parte 1/2)
Published in Reumatología clinica (01-07-2012)“…Resumen Glucocorticoides, aspirina, antipalúdicos e inmunosupresores convencionales constituyen la base del tratamiento del lupus eritematoso sistémico (LES)…”
Get full text
Journal Article -
6
New Targets in Systemic Lupus (Part 2/2)
Published in Reumatología clinica (Barcelona) (01-09-2012)“…Glucocorticoids, aspirin, conventional antimalarials and immunosuppressants are the mainstay of treatment of Systemic Lupus Erythematosus (SLE). Until…”
Get full text
Journal Article -
7
New Therapeutic Targets in Systemic Lupus
Published in Reumatología clinica (Barcelona) (01-07-2012)“…Glucocorticoids, aspirin, antimalarials and conventional immunosuppressants are the mainstay of treatment of Systemic Lupus Erythematosus (SLE). Until…”
Get full text
Journal Article -
8
End-stage renal disease after necrotising glomerulonephritis in an elderly patient with temporal arteritis
Published in Nephron (2015) (1994)Get more information
Journal Article